CDC to award task for analytical database that will assess the effectiveness of care of CKD in the Military Health System

Solicitation: 75D30120Q71863

The Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) intends to award a sole source firm-fixed price purchase order contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine Incorporated.

This requirement is in support of the NCCDPHP’s Division of Diabetes Translation (DDT). The purpose of this purchase order is to obtain contractor assistance to establish and support an analytical database that will assess the epidemiology, economic impact, and effectiveness of care of CKD in the MHS and contribute to the understanding of the impact of CKD in the United States.

This project will provide ongoing access to and evaluation of important public health surveillance data from the DoD electronic health records system, critical to the U.S. CKD policy efforts. It also allows for comparison of DoD CKD metrics to Healthy People 2020 CKD indicators and goals and for delineation of specific objectives which will require advanced surveillance capabilities to track progress.  This will be the only mechanism providing systemic analysis of this extremely valuable aggregated data.

The project will enable (1) the clinical leadership of the MHS to understand natural history trends and outcome factors in the incidence and prevalence of kidney injury and disease in the DoD beneficiary population, and (2) the scientific staff of the Centers for Disease Control and Prevention (CDC) to strengthen their CKD surveillance, epidemiology, economic, and health outcomes and policy initiatives.  This requirement is necessary for the NCCDPHP/DDT to accomplish the CDC’s mission.

Only the Henry M. Jackson Foundation for the Advancement of Military Medicine Incorporated is capable of meeting the CDC’s needs for this requirement.

Scope of Work:

  1. Conduct descriptive analyses of the prevalence and incidence of CKD and end-stage renal disease (ESRD) in MHS patients, including assessment of the important epidemiological associations among active-duty and non-active duty populations.
  2. Assess risk factors for the development of CKD in MHS patients to determine how they differ between active-duty and non-active-duty patients and the general population.

Read more here.

Advertisements

LEAVE A REPLY

Please enter your comment!
Please enter your name here